Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cue Biopharma (CUE) Other Non Operating Income (2018 - 2020)

Cue Biopharma's Other Non Operating Income history spans 3 years, with the latest figure at -$23000.0 for Q3 2020.

  • For Q3 2020, Other Non Operating Income fell 560.0% year-over-year to -$23000.0; the TTM value through Sep 2020 reached -$56922.0, down 139.71%, while the annual FY2019 figure was $64078.0, 61.24% down from the prior year.
  • Other Non Operating Income for Q3 2020 was -$23000.0 at Cue Biopharma, up from -$26000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $98000.0 in Q3 2018 and bottomed at -$26000.0 in Q1 2020.
  • The 3-year median for Other Non Operating Income is $3500.0 (2018), against an average of $18041.5.
  • The largest annual shift saw Other Non Operating Income skyrocketed 4700.0% in 2019 before it tumbled 560.0% in 2020.
  • A 3-year view of Other Non Operating Income shows it stood at $66337.0 in 2018, then tumbled by 119.48% to -$12922.0 in 2019, then tumbled by 77.99% to -$23000.0 in 2020.
  • Per Business Quant, the three most recent readings for CUE's Other Non Operating Income are -$23000.0 (Q3 2020), -$26000.0 (Q1 2020), and -$12922.0 (Q4 2019).